{ "case_number": "CAC-UDRP-107677", "time_of_filling": "2025-06-25 07:53:49", "domain_names": [ "novartis-rus.com" ], "case_administrator": " Iveta Špiclová (Czech Arbitration Court) (Case admin)", "complainant": [ "Novartis AG" ], "complainant_representative": "Abion GmbH", "respondent": [ "Customer Domain Admin (Nice IT Services Group Inc.)" ], "respondent_representative": null, "factual_background": "

The Novartis Group is one of the biggest global pharmaceutical and healthcare groups in the world. It has headquarters in Switzerland, and was created in 1996 through a merger of two other companies Ciba-Geigy and Sandoz, is the holding company of the Novartis Group Novartis AG (the “Complainant”)\/the Novartis group achieved net sales of USD 50.3 billion, and total net income of USD 11.9 billion in 2024 and employed approximately 76 000 people. The Complainant’s products are manufactured and sold in many countries worldwide including in Russia, where it has an active presence through associated companies and where it has been playing an active role on the local markets and societies. The disputed domain name, was registered on 13 May 2025. Nothing is known of the Respondent except that it is called the Nice IT Services Group Inc. and it is based in the Dominican Republic. The Complainant sent a cease-and-desist letter to it on 16 and 26 May and a follow up on 2 June and there was no response. <\/p>", "other_legal_proceedings": "

The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>", "no_response_filed": "

The Complainant contends that the requirements of the Policy have been met and that the disputed domain name should be transferred to it. No administratively compliant Response has been filed.<\/p>", "rights": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>", "no_rights_or_legitimate_interests": "

The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>", "bad_faith": "

The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>", "procedural_factors": "

The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision. The Panel accepts the request that the decision be in English.<\/p>", "decision": "Accepted", "panelists": [ "Victoria McEvedy" ], "date_of_panel_decision": "2025-08-01 00:00:00", "informal_english_translation": "

The Complainant is the owner of the registered well-known trademark NOVARTIS in numerous jurisdictions all over the world, including in Russia, such as but not limited to:<\/p>\n

    \n
  1. International trademark, designating Russia: NOVARTIS, Reg. No. 663765, Registration Date: 1 July 1996<\/li>\n
  2. International trademark, designating Russia: NOVARTIS, Reg. No. 1544148, Registration Date: 29 June 2020<\/li>\n
  3. International trademark, designating Russia: NOVARTIS, Reg. No. 1349878, Registration Date: 29 November 2016<\/li>\n
  4. International trademark, designating Russia: NOVARTIS, Reg. No. 666218, Registration Date: 31 October 1996<\/li>\n
  5. US trademark: NOVARTIS, Reg No. 4986124, Registration Date: 28 June 2016<\/li>\n
  6. US trademark: NOVARTIS, Reg. No. 6990442, Registration Date: 28 February 2023<\/li>\n
  7. EUTM: NOVARTIS, Reg. No. 000304857, Registration Date: 25 June 1999<\/li>\n
  8. EUTM, NOVARTIS, Reg. No. 013393641, Registration Date: 17 March 2015 A non-exhaustive list of all of the Complainant’s trademarks was submitted in evidence.<\/li>\n<\/ol>\n

    Moreover, previous UDRP Panels have stated that the NOVARTIS trademark is well-known (see Novartis AG v. Amartya Sinha, Global Webs Link, Novartis RO, WIPO Case No. D2020-3203). The Complainant owns numerous domain names which include its trademark NOVARTIS including (created on 2 April 1996), (created on 19 April 2002), (created on 1 June 2000) or in combination with other terms, such as (created on 27 October 1999). The Complainant uses these domain names to resolve to its official websites through which it informs Internet users and potential consumers about its NOVARTIS® mark and its related products and services. The Complainant also enjoys a strong presence online via its official social media platforms. <\/p>", "decision_domains": { "novartis-rus.com": "TRANSFERRED" }, "panelist": null, "panellists_text": null }